KinePict

What KinePict does

Kinepict is a privately-held medical imaging software company founded in 2015 and headquartered in Budapest, Hungary, with a secondary contact office in Atlanta, Georgia. The company develops and commercialises the Kinepict Medical Imaging Tool (KMIT), a platform-independent software application built on its proprietary Digital Variance Angiography (DVA) technology. DVA is a patented, motion-based computational imaging method that processes unsubtracted DSA image series from any major angiography system (GE, Philips, Siemens) and generates enhanced vascular visualisations (DVA1, DVA2, and color-coded ccDVA outputs). Peer-reviewed clinical studies report that the technology enables up to 70% reduction in X-ray radiation dose and up to 50% reduction in iodinated contrast media use during interventional procedures, with additional applicability to CO2 angiography for renal-impaired patients.

Kinepict targets interventional radiology and vascular surgery departments in hospitals across Europe and (more recently) the United States. Its product is regulatory-cleared under CE Mark, ISO 13485:2016, and FDA 510(k) and supports DICOM export to hospital PACS systems with built-in anonymisation. The commercial model is enterprise software licensing, with annual billing under quote-based pricing and machine-ID-locked activation; revenue is supplemented by post-sales support and updates. The company sells direct in Hungary and through a network of channel partners — most notably AngioPro GmbH, which covers 17 European markets — supplemented by DVA IntelTech (Romania) and Gama Medikal (Turkey).

The company has been primarily funded by non-dilutive public sources, including an EIC Accelerator grant, NKFI GYORSÍTÓSÁV 2021, an H2020 SME Instrument Support Grant, a START-UP_13 Technology Incubation Grant, and an Industrial Property Rights Protection Grant — augmented by early-stage investment from FastVentures and Euroventures. Kinepict maintains named clinical collaborations with key opinion leaders at major European university hospitals (Uniklinikum Giessen/Marburg, Uniklinik Frankfurt, Klinikum Nürnberg, Universitätsklinikum Aachen, Policlinico Umberto I, Vascular Centre Clinic Arnsberg, and others), which generate the peer-reviewed publications underpinning its clinical-evidence moat.

Name

KinePict

Legal name

Kinepict

Website

https://kinepict.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Kinepict develops proprietary Digital Variance Angiography (DVA) software that enhances vascular imaging during interventional procedures, enabling hospitals to reduce X-ray radiation and iodinated contrast media use.

Ownership category

akta.pro rank

Product category

Medical Imaging Software

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLACANAG

SaMD – Imaging & Signal Analysis (AI/ML)

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

SECONDARYHLAHABAG

Interventional Radiology & Image-Guided Therapy Systems

Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

SECONDARYHLACALAK

Teleradiology Platforms & Reading Workflow

Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

• Digital subtraction angiography
• Vascular imaging software
• Contrast media reduction
• Interventional radiology software
• X-ray dose reduction

Headquarters

HQ city

Budapest

HQ country

Hungary

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Software Licensing: Kinepict Medical Imaging Tool (KMIT) is licensed to healthcare institutions. The registration system indicates license-based access for the software. Deployment involves installation on hospital angiography systems with encrypted machine ID licensing.
2. Enterprise Software Subscription: License management system indicates recurring access to the medical imaging software with support and updates included.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Kinepict develops and licenses the Kinepict Medical Imaging Tool (KMIT), a platform-independent medical imaging software that receives Digital Subtraction Angiography (DSA) image series from any angiography system and uses proprietary Digital Variance Angiography (DVA) technology to generate enhanced vascular visualizations (DVA1, DVA2, ccDVA). The software enables up to 70% reduction in X-ray radiation dose and up to 50% reduction in iodinated contrast media usage during interventional radiology and vascular surgery procedures.

Product overview

Kinepict offers a single unified product — the Kinepict Medical Imaging Tool (KMIT) — built on its proprietary Digital Variance Angiography (DVA) technology. KMIT is platform-independent software that receives DSA (Digital Subtraction Angiography) unsubtracted image series from any angiography system, processes them through DVA-based algorithms, and delivers enhanced vascular visualizations (DVA1, DVA2, ccDVA) back into the clinical workflow. The product supports dose-reduction and contrast-media-reduction workflows, integrates with hospital PACS systems for image export, and is offered through a licensing model (user registration/sign-up) to healthcare institutions.

Differentiator

Problem solved

Functional benefit

Brands

• KMIT: Kinepict Medical Imaging Tool - platform-independent software solution that processes angiography image series and generates enhanced views to support clinical interpretation.
• DVA

Products and services

• Kinepict Medical Imaging Tool (KMIT) A platform-independent medical imaging software that receives DSA image series from any angiography system and uses Digital Variance Angiography (DVA) technology to generate enhanced vascular visualizations (DVA1, DVA2, ccDVA) for interventional radiology and vascular surgery departments. Features brightness/contrast adjustment, pixel shift correction, anatomical background toggle, PACS export in DICOM, and DICOM anonymization.
• Digital Variance Angiography (DVA) Kinepict's proprietary core imaging technology that processes angiography image series using motion-based variance analysis to produce enhanced vascular images (DVA1, DVA2, ccDVA), enabling improved vessel visibility, reduced noise, and dose/contrast-reduction workflows across interventional radiology and vascular surgery procedures.

Quantifiable outcome

• 70% reduction in DSA-related radiation exposure in lower limb X-ray angiography (validated in randomized controlled trial)
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core and regional.

• AngioPro GmbHcoreChannel Partner/ Reseller/ DistributorRegional distribution partner covering Austria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Italy, Latvia, Lithuania, Norway, Poland, Portugal, Spain, Sweden, Switzerland. Website: angiopro.de
• DVA IntelTechregionalChannel Partner/ Reseller/ DistributorDistribution partner for Romania market. Contact: [email protected]
• Gama MedikalregionalChannel Partner/ Reseller/ DistributorDistribution partner for Turkey market. Website: gamamedikal.com.tr, Contact: [email protected]
• Dr. Michael LichtenbergcoreStrategic or Co-development PartnerChief Medical Officer of Angiology Department at Vascular Centre Clinic, Arnsberg, Germany. Collaboration began 2023 focusing on dose reduction and contrast dilution. Siemens Artis Zee system.
• Prof. Andreas MahnkencoreStrategic or Co-development PartnerUniklinikum Giessen und Marburg. Cooperation started 2019, resulting in two peer-reviewed publications on DVA advantages. Clinical studies demonstrated DVA usability in lower-limb angiography with metal implants.
• Dr. Thomas VoglcoreStrategic or Co-development PartnerUniklinik Frankfurt. Collaboration started 3 years ago focusing on DVA use in embolization settings (PAE and TACE). Regular use in daily work.
• Prof. Eric VerhoevencoreStrategic or Co-development PartnerKlinikum Nürnberg. Cooperation started 2018 resulting in scientific presentations at CIRSE, RSNA, ESVS on DVA use in fenestrated/branched EVAR procedures.
• Dr. Mohammad E. BarbatiregionalStrategic or Co-development PartnerUniversitätsklinikum Aachen. Project on DVA usefulness in Chronic Venous Occlusions aiming for substantial radiation exposure reduction.
• Dr. Zoltán HarmatregionalStrategic or Co-development PartnerPremier G. Med, Budapest. Uses Kinepict technology for myoma embolization procedures. GE Innova system.
• Dr. Pierlone LucatellicoreStrategic or Co-development PartnerPoliclinico Umberto I, Italy. Focus on DVA benefits in liver TACE procedures with emphasis on iodinated contrast media reduction. Active partnership with international experts.
• MTA (Hungarian Academy of Sciences)coreStrategic or Co-development PartnerResearch collaboration relationship indicated on company page with MTA Kiv Kut (Scientific Publication Award) visible.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Medis Medical Imaging Systems: Dutch vendor of cardiovascular and angiographic imaging analysis software (QAngio, QFlow) used in interventional radiology and vascular surgery workflows — the closest functional peer to Kinepict as a third-party angiography image enhancement/quantification add-on for hospitals.
• Pie Medical Imaging: Specializes in cardiovascular and angiographic image post-processing and analysis software used by interventional cardiologists and radiologists, with comparable image enhancement, quantification, and PACS integration capabilities to KMIT.
• Circle Cardiovascular Imaging: Provides cardiovascular MR, CT and angiography post-processing software (cvi42) widely used in vascular and interventional workflows, addressing the same hospital IR/cath lab buyers as Kinepict with similar evidence-led go-to-market.
• TeraRecon (now ConcertAI): Advanced visualization and AI imaging platform for radiology, including angiography and vascular workflows; competes with Kinepict on enterprise hospital image post-processing with broader modality coverage and deeper US presence.

Broad incumbents

• Siemens Healthineers (syngo.via): OEM incumbent offering native angiography image post-processing within its Artis platform (syngo.via), the largest competitive threat to Kinepict because it ships dose-reduction and image enhancement natively, requiring no third-party integration.
• Philips IntelliSpace Portal: OEM incumbent offering multi-modality image post-processing integrated with its IGT-DR angiography systems, a competitor and also a potential partner/OEM channel for KMIT given Philips' installed base in European cath labs.
• GE Healthcare (Edison / AW Workstation): OEM incumbent providing AW Workstation and Edison-platform post-processing and AI imaging capabilities integrated with its IGS angiography systems, positioned to embed native dose-reduction features that overlap with KMIT's value proposition.
• Canon Medical (Vitrea): Vitrea advanced visualization platform offers multi-modality post-processing including angiography; competes in the same hospital radiology suites Kinepict targets, though less dominant in interventional angiography workflows.

Emerging players

• Arterys (Tempus): Cloud-AI medical imaging platform for cardiac and vascular MR/CT, acquired by Tempus; overlaps with Kinepict in the AI-driven vascular imaging augmentation category and represents where third-party AI image enhancement is heading commercially.
• Brainlab: Operates a broad surgery/imaging visualization platform used in interventional and vascular procedures; overlapping hospital buyer base and similar enterprise software motion, with broader portfolio scope than Kinepict.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@kinepict
• LinkedInlinkedin.com/company/kinepict-ltd

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KinePict